Scandinavian Biopharma is a Swedish research-based biotech company specialist in marketing and sales of vaccines, immunoglobulin’s, biodefense, antidotes and diagnostic tests. Scandinavian Biopharma received € 3.0M from the SME Instrument HORIZON 2020, phase 2.
“The contribution from the EU Commission is a strong recognition of our research, which strives toward developing a globally unique ETEC vaccine. The EU grant will be used to accelerate the clinical development of the vaccine and to take a significant step towards commercialisation. GAEU Consulting has been responsible for our application. We are very satisfied with the quality of the work effort and commitment from the team in Kraków”
Björn Sjöstrand, CEO, Scandinavian Biopharma